Johnson & Johnson JNJ
NYSE JNJ
$270.24 +2.87 (+1.07%)
At close: Aug 21, 2026 · 4:00 PM EDT

Johnson & Johnson (JNJ) Cash & Current Investments (2009 - 2026)

Johnson & Johnson (JNJ) posted Cash & Current Investments of $20.8 billion for Q2 2026, down 5.86% sequentially from $22.1 billion in Q1 2026, and up 9.95% YoY from $18.9 billion in Q2 2025.

Johnson & Johnson (JNJ) Cash & Current Investments (2009 - 2026) Analysis & Trends

Johnson & Johnson has reported Cash & Current Investments for 18 years, with the latest figure at $20.8 billion in Q2 2026.

  • Quarterly Cash & Current Investments rose 9.95% year-over-year to $20.8 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $20.8 billion (up 9.95% YoY) and the FY2025 annual result came in at $20.1 billion, down 18.02% from the prior year.
  • Cash & Current Investments declined to $20.8 billion in Q2 2026 per JNJ's latest filing, from $22.1 billion in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $38.8 billion in Q1 2025 and troughed at $18.6 billion in Q3 2025.
  • A 5-year average of $25.6 billion and a median of $24.5 billion in 2024 frame the typical range for Cash & Current Investments.
  • The sharpest annual moves came in 2025 and 2026: Cash & Current Investments soared 47.92% in 2025, then tumbled 43.14% in 2026.
  • Over 5 years, Cash & Current Investments stood at $34.1 billion in 2022, then sank by 32.72% to $22.9 billion in 2023, then climbed by 6.96% to $24.5 billion in 2024, then decreased by 18.02% to $20.1 billion in 2025, then advanced by 3.26% to $20.8 billion in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods registered $20.8 billion, $22.1 billion, and $20.1 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn 20.76 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn 6.57 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn 7.14 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn 7.69 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn 4.90 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn 13.99 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn 3.18 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn 11.70 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn 4.17 Bn
10 Sanofi 55.07 Bn 47.69 Bn 10.79 Bn 7.38 Bn

Historic Data

Download Data
DateValue
Jun 28, 2026 20.76 Bn
Mar 29, 2026 22.05 Bn
Dec 28, 2025 20.10 Bn
Sep 28, 2025 18.56 Bn
Jun 29, 2025 18.88 Bn
Mar 30, 2025 38.78 Bn
Dec 29, 2024 24.52 Bn
Sep 29, 2024 20.30 Bn
Jun 30, 2024 25.48 Bn
Mar 31, 2024 26.22 Bn
Dec 31, 2023 22.93 Bn
Oct 1, 2023 23.51 Bn
Jul 2, 2023 28.51 Bn
Apr 2, 2023 24.61 Bn
Jan 1, 2023 22.28 Bn
Oct 2, 2022 34.08 Bn
Jul 3, 2022 32.57 Bn
Apr 3, 2022 30.39 Bn
Jan 2, 2022 31.61 Bn
Oct 3, 2021 31.00 Bn